SENSEX 83878.17 (0.36)
Nifty Bank 59450.5 (0.34)
Nifty Smallcap 100 17193.3 (-0.52)
Nifty Next 50 68699.05 (0.30)
Nifty Pharma 22668.45 (-0.41)
Nifty IT 37988.25 (-0.10)
Nifty Midcap 100 59717.1 (-0.05)
Nifty 50 25790.25 (0.42)
NIKKEI 225 53583.93 (3.17)
HANG SENG 26608.48 (1.44)
S&P 6997.71 (0.15)
11-Nov-2025
OP down 28.72%
'On consolidated basisQuarter ended September 2025 compared with Quarter ended September 2024. Net sales (including other operating income) of Emami has declined 10.34% to Rs 798.51 crore. Sales of Within India segment has gone down 14.86% to Rs 618.32 crore (accounting for 77.43% of total sales). Sales of Outside India segment has gone up 9.66% to Rs 180.19 crore (accounting for 22.57% of total sales). Operating profit margin has declined from 28.12% to 22.36%, leading to 28.72% decline in operating profit to Rs 178.53 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 22.15% to 23.14%. Purchase of finished goods cost rose from 10.61% to 11.42%. Employee cost increased from 12.05% to 13.99%. Other expenses rose from 28.43% to 30.86%. Selling and administration expenses rose from 15.56% to 18.05%.
Other income f...
(13-Jan-2026)
Revenue up 4.9% YoY to Rs 67087 crore in Q3FY2026
(12-Jan-2026)
Revenue up 116.8% YoY to Rs 659 crore in Q3FY2026
(11-Jan-2026)
Revenue up 13.3% YoY to Rs 18100.9 crore, Net profit up 18.3% yoy to Rs 855.9 crore in Q3FY2026
(09-Jan-2026)
Sales up 4%, net down 33%
Results-Analysis (11-Nov-2025)
Results-Analysis (01-Aug-2025)
Sales remain flat, while NP increased 7.61%
Results-Analysis (28-Jan-2025)
OP up 7.57%
Results-Analysis (08-Nov-2024)
NP up 19.14%